The US FDA inspected Unit-V, an API manufacturing facility, of Apitoria Pharma, a wholly-owned subsidiary of the company

Aurobindo Pharma announced that the United States Food and Drug Administration (FDA) completed an inspection of Unit-V, an active pharmaceutical ingredient (API) manufacturing facility of its wholly-owned subsidiary, Apitoria Pharma.

The company in a regulatory filing mentioned that the United States Food and Drug Administration (US FDA) inspected Unit-V, an API manufacturing facility, of Apitoria Pharma, a wholly-owned subsidiary of the company, situated at Pashamylaram Village, Patancheru Mandal, Sanga Reddy District, Telangana from December 9 to December 17.

The FDA closed the inspection with two observations, which are described as procedural in nature.